CRBP — Corbus Pharmaceuticals Holdings Share News
0.000.00%
Last trade - 00:00Corbus Pharmaceuticals Holdings Inc reports results for the quarter ended March 31 - Earnings Summary
Corbus Pharmaceuticals Holdings Inc expected to post a loss of $1.28 a share - Earnings Preview
Brief: Corbus Pharmaceuticals' cash runway expected through third-quarter 2027
Corbus Pharmaceuticals Holdings Inc reports results for the quarter ended December 31 - Earnings Summary
U.S. RESEARCH ROUNDUP-Autodesk, Coca-Cola, NetApp
Corbus Pharmaceuticals Holdings Inc reports results for the quarter ended in September 30 - Earnings Summary
Brief: Corbus Announces Enrollment Completion Of Dose Escalation Stage Of Phase 1 Clinical Trial Of Its Next Generation Nectin-4 Targeting ADC (CRB-701)
U.S. RESEARCH ROUNDUP-Costco Wholesale, McKesson, Starbucks
U.S. STOCKS ON THE MOVE-Copper miners, Visa, Lifeway Foods
U.S. STOCKS ON THE MOVE-Copper miners, Visa, Bluebird bio
Corbus falls after Mizuho cuts PT on weakness in obesity, cancer drug candidates
U.S. RESEARCH ROUNDUP-Cardinal Health, Factset, Paylocity Holding
U.S. STOCKS ON THE MOVE-Visteon, Olo, Arcadium Lithium
U.S. STOCKS ON THE MOVE-Newmont, Nike, Harmony Gold Mining
Corbus drops after rival Novo Nordisk reports obesity drug data
U.S. STOCKS ON THE MOVE-Lumen Technologies, Insulet, PDD Holdings
U.S. STOCKS ON THE MOVE-Eli Lilly, JD.com, Super Micro Computer
U.S. STOCKS ON THE MOVE-Trinity Biotech, Cava Group, Paramount Global
Mizuho starts coverage on Corbus Pharma with 'outperform'